Russia readies for approval of second COVID-19 vaccine - official


  • World
  • Wednesday, 26 Aug 2020

A handout photo shows an employee demonstrating a vial with "Gam-COVID-Vac" vaccine against the coronavirus disease (COVID-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. Picture taken August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS

MOSCOW (Reuters) - Russia is preparing to approve a second vaccine against COVID-19 in late September or early October, Russian Deputy Prime Minister Tatiana Golikova said on Wednesday.

Speaking at a televised government meeting, Golikova told President Vladimir Putin that early-stage clinical trials on the vaccine, developed by the Vector virology institute in Siberia, would be completed by the end of September.

Celebrate Merdeka with 50% Off!
T&C applies.

Monthly Plan

RM13.90/month
RM6.95 only

Billed as RM6.95 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM6.17/month

Billed as RM78 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Musk calls Australian government 'fascists' over misinformation law
Philippine 'Son of God' preacher pleads not guilty to sex trafficking charge
Govt of US city falsely accused by Trump over eating pets evacuated due to bomb threat by anti-immigration local
Venezuela calls on diplomats as Spain feud intensifies
Worsening Sinaloa Cartel war paralyzes life in Mexican city
North Korea shows first photos of banned uranium enrichment site
North Dakota judge overturns state abortion ban
New data show U.S. adult obesity prevalence remains high
U.S. stocks close higher after latest inflation data
Roundup: Chinese firms explore business opportunities at homelife expo in Los Angeles

Others Also Read